glp 1 agonist diabetes GLP-1 Receptor Agonists: A Game-Changer for Type 2 How GLP-1 Receptor Agonists Evolved

Breastfeeding considerations and GLP-1 use during lactation require careful medical guidance regardless of which alternative you choose

Implications for employers: Although almost half of employers stated that they were interested in the potential for compounded GLP-1 medications, according to WTWs 2025 Best Practices in Healthcare Survey, only 7% said they were very interested, and there has been very little employer uptake of compounded medications

In another report, a 26week treatment with the GLP1R/GIPR dual agonist LY3298176 (Tirzepatide, Eli Lilly), showed significant reduction in A1c in an incremental, dosedependent manner (4 doses from 1 mg to 15 mg, A1c reduction from 1.06% to 1.94% respectively)

6 Kidney disease is common among individuals with type 2 diabetes, as high blood sugar damages kidney blood vessels

Beyond their role in glucose metabolism, GLP-1 and its receptor agonists have emerged as multifunctional agents with broad cardiometabolic, renal, and immunomodulatory benefits

Some researchers have moved their eyes to small-molecule GLP-1RA - with high oral bioavailability, and high patient compliance